Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients

Journal of Supportive Oncology

Volumn 7, Issue 1, 2009, Pages 39-46

  Slatkin, Neal ^{a,b,c,d,e,f,g,h,i,j}   Thomas, Jay ^{a,b,c,d,e,f,g,h,i,j}   Lipman, Arthur G ^{a,b,c,d,e,f,g,h,i,j}   Wilson, George ^{a,b,c,d,e,f,g,h,i,j}   Boatwright, Michelle L ^{a,b,c,d,e,f,g,h,i,j}   Wellman, Charles ^{a,b,c,d,e,f,g,h,i,j}   Zhukovsky, Donna S ^{a,b,c,d,e,f,g,h,i,j}   Stephenson, Richard ^{a,b,c,d,e,f,g,h,i,j}   Portenoy, Russell ^{a,b,c,d,e,f,g,h,i,j}   Stambler, Nancy ^{a,b,c,d,e,f,g,h,i,j}   Israel, Robert ^{a,b,c,d,e,f,g,h,i,j}  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Institute for Palliative Medicine at San Diego Hospice   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e LifePath Hospice and Palliative Care Inc   (United States)

^f Hospice of the Western Reserve   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h Hospice and Palliative Care Center   (United States)

ⁱ BETH ISRAEL MEDICAL CENTER   (United States)

^j A Subsidiary of Lantheus Holdings   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; OPIATE; PLACEBO; DRUG DERIVATIVE; MU OPIATE RECEPTOR; NALTREXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; QUATERNARY AMMONIUM DERIVATIVE;

ABDOMINAL PAIN; ADULT; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL EVALUATION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DELIRIUM; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DYSPNEA; FATIGUE; FEMALE; FLATULENCE; FLUSHING; HALLUCINATION; HUMAN; HYPERTENSION; INJECTION SITE BURNING; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; NAUSEA; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESSNESS; RHINORRHEA; SCORING SYSTEM; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; SWEATING; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; UNCONSCIOUSNESS; VOMITING; AGED; ANALGESIA; CHEMICALLY INDUCED DISORDER; CRITICAL ILLNESS; DEFECATION; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALGESIA; ANALGESICS, OPIOID; CONSTIPATION; CRITICAL ILLNESS; DEFECATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, OPIOID, MU; TREATMENT OUTCOME;

EID: 64849097928     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med 1998;12:375-382.
2. NCCN Clinical Practice Guidelines in Oncology: Palliative Care. V.1.2009. Available at: www.nccn.org/professionals/physician_gls/PDF/ palliative.pdf. Accessed January 14, 2009.
3. Sykes N. Constipation and diarrhoea. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford Textbook of Palliative Medicine. 3rd ed. Oxford: Oxford University Press; 2004:483-495.
4. Sykes NP. A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 1996;11:363-369.
5. Fakata KL, Lipman AG. Gastrointestinal opioid physiology and pharmacology. In: Yuan CS, ed. Handbook of Opioid Bowel Syndrome. New York, NY: Haworth Medical Press; 2005:101-120.
6. Van Nueten JM, Van Ree JM, Vanhoutte PM. Inhibition by met-enkephalin of peristaltic activity in the guinea pig ileum, and its reversal by naloxone. Eur J Pharmacol 1977;41:341-342.
7. Sykes NP. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat Med 1996;10:135-144.
8. Sykes NP. Oral naloxone in opioid-associated constipation. Lancet 1991;337:1475.
9. Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 2002;23:48-53.
10. Russell J, Bass P, Goldberg LI, Schuster CR, Merz H. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol 1982;78:255-261.
11. Amin HM, Sopchak AM, Foss JF, Esposito BF, Roizen MF, Camporesi EM. Efficacy of methylnaltrexone versus naloxone for reversal of morphine-induced depression of hypoxic ventilatory response. Anesth Analg 1994;78:701-705.
12. Murphy DB, Sutton JA, Prescott LF, Murphy MB. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 1997;87:765-770.
13. Yuan CS, Foss JF, O'Connor M, et al. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time. Clin Pharmacol Ther 2000;67:398-404.
14. Yuan CS, Foss JF, O'Connor M, Osinski J, Roizen MF, Moss J. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain 1999;83:631-635.
15. Yuan CS, Foss JF, O'Connor M, Toledano A, Roizen MF, Moss J. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 1996;59:469-475.
16. Yuan CS, Foss JF, O'Connor M, et al. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial. JAMA 2000;283:367-372.
17. Yuan CS, Foss JF. Oral methylnaltrexone for opioid-induced constipation. JAMA 2000;284:1383-1384.
18. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;358:2332-2343.
19. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 5th ed. Glenview, Ill: American Pain Society; 2003.
20. The Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD Clinical Practice Guideline for the Management of Opioid Therapy for Chronic Pain. Washington, DC: Department of Veteran Affairs, Department of Defense; 2003.
21. Portenoy RK, Thomas J, Moehl Boatwright ML, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 2008;35:458-468.